Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience
Conclusions: SMART provided promising oncologic outcomes at the cost of significant treatment related morbidity. Due to the significant treatment associated morbidity and favorable treatment alternatives, we have not broadly adopted SMART at our institution.
Journal of Laparoendoscopic&Advanced Surgical Techniques, Ahead of Print.
CONCLUSIONS: The HRQOL of hemodialysis patients with CKD-FS remains poor, interacting with important functions such as sleep, vitality, cognition, and sexual function. PMID: 32468308 [PubMed - in process]
Authors: Kapodistrias N, Theocharopoulou G, Vlamos P Abstract MicroRNAs are short non-coding RNA molecules that control posttranscriptional gene expression and are present in tissues cells but also circulate in biological fluids in various forms (exosome, connected with proteins, apoptotic bodies, etc.). The roles that circulated extracellular serum microRNAs possess in cancer development, like in the delivery from a recipient cell to distant tissues and the repression of host genes resulting in the impairment of critical functions, are still undetermined. Disturbances, such as the higher incidence of atrial fibril...
Conclusions: Our approach is feasible, reproducible and can guide novel therapeutic choices in this poor prognosis cohort, where new treatment options are urgently needed. This platform is relevant to many solid organ malignancies.
In conclusion, we highlight a novel and clinically exploitable pathway in high-risk EZH2 mutated T-ALL.
We examined 329 patients from February 2002 to July 2013. There were 131 MPM cases with ADA levels of 32.29 IU/L; 117 LC cases with ADA levels of 21.12 IU/L; 54 benign disease cases with ADA levels of 20.98 IU/L. A significant difference existed in pleural effusion ADA levels between MPM and benign disease patients. Pleural effusion ADA levels were significantly higher in MPM patients. PMID: 32468861 [PubMed - as supplied by publisher]
Authors: Moussa M, Papatsoris A, Abou Chakra M, Sryropoulou D, Dellis A Abstract INTRODUCTION: Metastatic castration-resistant prostate cancer (CRPC) is a potentially symptomatic disease with an eventual lethal outcome. Novel pharmaceutical agents are continuously studied with encouraging results in CRPC. AREAS COVERED: In this perspective, the authors present established and promising pharmacotherapeutic strategies for the management of CRPC; both with and without metastases. Apart from the different treatment strategies, the authors present the relevant sequence of treatment through disease progression. E...
ConclusionsA temperature-guided approach affords freedom from AF at a 3-year follow-up period in a large majority of patients affected by PAF having undergone a single CB-A procedure.
Publication date: Available online 29 May 2020Source: Colloids and Surfaces B: BiointerfacesAuthor(s): Changyong Guo, Qirong Wang, Xingjie Zhang, Fengkun Lu, Miao Sun, Peiyu Zeng, Linhong Sun, Lan She, Bingkai Wang, Yunchang Zhang, Chen Wang, Zhiqiang Ma, Feng Yang
Publication date: Available online 29 May 2020Source: Journal of Taibah University Medical SciencesAuthor(s): Mohammed A. Bawahab
More News: Asbestosis | Atrial Fibrillation | Bronchoscopy | Cancer & Oncology | Chemotherapy | Dialysis | Intensity-Modulated Radiation Therapy | Laparoscopy | Mesothelioma | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Radiation Therapy | Renal Failure | Respiratory Medicine | Toxicology | Tracheostomy